Home > Boards > US Listed > Medical - Drugs > Noven Pharmaceuticals Inc. (NOVN)

$NOVN / #NOVA #Pharmaceuticals On Day Trade Watch List

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
TFMG Member Profile
Member Level 
Followed By 59
Posts 2,204
Boards Moderated 4
Alias Born 04/28/19
160x600 placeholder
Novan Receives Approval to Transfer to Nasdaq Capital Market GlobeNewswire Inc. - 11/4/2020 7:30:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 10/30/2020 7:48:35 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/30/2020 7:37:33 AM
Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire Inc. - 10/30/2020 7:30:10 AM
Novan to Present at the Virtual Investor KOL Roundtable GlobeNewswire Inc. - 10/21/2020 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/14/2020 7:06:52 AM
Novan’s NITRICIL™ Technology Shows In Vitro Antiviral Effect Against SARS-CoV-2 in Human Airway Infection Model GlobeNewswire Inc. - 10/14/2020 7:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/25/2020 8:33:16 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/25/2020 8:32:05 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2020 7:11:24 AM
Novan Strengthens Financial Leadership with Appointments of Chief Financial Officer and Seasoned Industry Executive to Board ... GlobeNewswire Inc. - 9/24/2020 7:05:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2020 9:09:20 AM
Novan Provides Pipeline and Priority Development Programs Update GlobeNewswire Inc. - 9/14/2020 9:05:10 AM
Novan to Present at the H.C. Wainwright 22nd Annual Global Investment Conference GlobeNewswire Inc. - 9/9/2020 8:05:10 AM
Novan Announces First Patient Enrolled and Dosed in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum GlobeNewswire Inc. - 9/3/2020 9:05:10 AM
Novan Initiates B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum GlobeNewswire Inc. - 8/31/2020 8:05:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/19/2020 4:16:21 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2020 7:18:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/28/2020 8:10:38 AM
Novan President and CEO, Paula Brown Stafford Named Chairman of the Board GlobeNewswire Inc. - 7/28/2020 8:05:10 AM
Novan to Host Live Audio Webcast of 2020 Annual Meeting of Stockholders GlobeNewswire Inc. - 7/23/2020 8:05:10 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 7/23/2020 6:03:29 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/22/2020 7:05:46 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/16/2020 4:46:09 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/15/2020 8:01:01 AM
TFMG Member Level  Friday, 10/16/20 12:02:11 PM
Re: None
Post # of 1368 

$NOVN | #NOVA #Pharmaceuticals On Day Trade Watch List


Novan, Inc. is a biotechnology company, which engages in leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. Its products pipeline include SB204, SB206, SB208, and SB414. The company was founded by Mark Schoenfisch and Nathan Stasko in 2006 and is headquartered in Morrisville, NC .





Official InvestorsHub (IHUB) Profile for #TFMG | #theFinancialMarketingGroup:

#BullishCharts - https://investorshub.advfn.com/BullishChartscom-38003/

#TopMarketGainers - https://investorshub.advfn.com/Chart-Analysis-TopMarketGainerscom-36847/
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences